Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Non Operating Income (2023 - 2025)

Historic Non Operating Income for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $2.2 million.

  • Metagenomi's Non Operating Income rose 4707.45% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 8276.02%. This contributed to the annual value of $5.3 million for FY2024, which is 7081.69% down from last year.
  • As of Q3 2025, Metagenomi's Non Operating Income stood at $2.2 million, which was up 4707.45% from $1.1 million recorded in Q2 2025.
  • Metagenomi's Non Operating Income's 5-year high stood at $6.9 million during Q2 2023, with a 5-year trough of -$4.0 million in Q4 2024.
  • Its 3-year average for Non Operating Income is $2.7 million, with a median of $3.6 million in 2023.
  • As far as peak fluctuations go, Metagenomi's Non Operating Income plummeted by 20978.5% in 2024, and later surged by 4707.45% in 2025.
  • Metagenomi's Non Operating Income (Quarter) stood at $3.6 million in 2023, then crashed by 209.79% to -$4.0 million in 2024, then surged by 155.54% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $1.1 million for Q2 2025, and $2.9 million during Q1 2025.